Where an R&D entity has had an offset for R&D expenditure or R&D asset decline in value and receives or becomes entitled to amounts for the results, for access to or use of the results, attributable to incurring the expenditure or using the asset (including amounts receivable regardless of results), or from disposing of or granting rights over a CGT asset that gave another person access to the results, it includes each amount in assessable income (for a disposal, the excess over the asset's cost or cost base); partners of R&D partnerships include their proportion.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.